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Abstract
Background: A subset (~8-15%) of the patients born with esophageal atresia (EA) 
suffer from a lack of esophageal tissue, which makes a primary anastomosis difficult 
to achieve. This is most common in patients born without a distal fistula between the 
trachea and the distal esophageal segment.
Purpose: To investigate the clinical course and outcome in patients born with long-
gap esophageal atresia (LGEA) in the western region of Sweden and to develop an 
experimental model of guided tissue regeneration in the intrathoracic esophagus.
Methods: A retrospective study of 16 consecutive patients born with LGEA between 
1995 and 2010 was performed. The patients had been followed according to a struc-
tured program at one and seven years of age. The experimental studies had been 
performed in growing piglets, where 3 cm of the intrathoracic esophagus had been 
replaced with a silicone stented Biodesign® mesh. The piglets were provided with a 
gastrostomy through a small midline laparotomy. Factors influencing the clinical and 
histological outcome had been recorded. In Paper II, six piglets underwent surgery, in 
Paper III, ten and, in Paper IV, six. 
Results: No mortality was seen in the patients with LGEA. The mean age at definitive 
surgery was 147 days. The patients were small for gestational age. Eleven of sixteen 
(70%) had a delayed primary anastomosis as a definitive procedure, three had a gas-
troplasty and two underwent a colonic interposition. After surgery, anastomotic leak-
age was seen in seven of 16 (45%) patients and stricture developed in 11 of 16 (70%).
At follow-up, some catch-up in weight was seen at seven years of age, but no catch-up 
in stature was seen.
Spirometry performed at one and seven years of age showed obstruction or restriction 
in 9 of 14 (55%) measurements. The spirometry findings did not indicate any further 
need for surgery. Multiple breath washout was within the normal range in 11 of 15 
(75%) measurements at one and seven years of age. Three of four (75%) of the patients 
with a pathological lung clearance index (LCI) at multiple breath washout required 
further surgery to prevent pulmonary damage due to aspiration.
All patients either underwent surgery or were receiving continuous medical treatment 
for gastroesophageal reflux, and 7 of 16 (45%) had gastrostomy at the end of the study 
period. All patients were able to drink orally, but two of 16 (13%) were unable to eat 
solid foods. 
In the first experimental study (Paper II), six animals lived for one to 17 weeks after 
surgery. Four animals were alive for at least four weeks and in two of them (50%) the 
stent was lost prior to four weeks. Piglets that lived longer than four weeks had recur-
rent stricture and required dilation. Histology showed connective tissue and intense 
angiogenesis in three piglets. In two of them, living four and 17 weeks respectively 
after surgery, the bridging area contained islets of immature-looking cells  in the 
submucosa. The remaining three piglets only had inflammatory cells and fibrosis in 
the bridging area.
In Paper III, the piglets lived for three to 10 days after surgery. Three of 10 (30%) ani-
mals were sacrificed prior to plan due to mediastinitis. The surgical method was devel-
oped in such a way that the bridging graft could be sewn without leakage. If there was 
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no significant leakage, the bridging graft was macroscopically surrounded by a tissue 
tube that connected the native esophageal edges. Histology showed connective tissue 
and inflammatory cells with intense angiogenesis in the bridging area. In addition, 
a thin layer of smooth muscle cells was seen around the bridging graft. In the piglets 
with significant leakage, there was an aggressive inflammatory pattern, with macro-
phages in the native muscle layers and islets of lymphocytes in the bridging area.
In Paper IV, all the piglets survived until sacrifice 20 days after surgery. In two of six 
(33%) piglets, there was stent loss prior to sacrifice. In the animals with a retained 
stent, the tissue tube between the native muscle edges was easily dissected macroscopi-
cally. If the stent was lost, the bridging area was narrow and attached to the surround-
ing tissues with firm adhesions. Histology in the piglets with a retained stent showed 
that the bridging area was organized in three layers with islets of smooth muscle cells 
organized in two layers in the wall. CD163-positive, M2 machrophages were seen 
close to the lumen. In those animals in which the stent was lost, the organization 
into three layers could not be seen. There were no M2 macrophages in the specimen, 
but calprotectin-positive, M1 macrophages could be seen throughout the wall of the 
bridging area.
Conclusion: Patients in our study born with LGEA required long hospitalization and 
suffered from symptoms related to gatroesophageal reflux during childhood. These 
individuals were small for gestational age. Some catch-up in weight was seen at seven 
years of age, but no catch-up in stature was seen. Multiple breath washout might be a 
valuable tool for the early detection of aspiration into the lungs in this patient group. 
The experimental model for replacing a part of the intrathoracic esophagus in grow-
ing piglets showed that a remodeling inflammatory pattern, accumulation of muscle 
cells and a structured overall organization in the wall of the bridging graft can be 
achieved under favorable conditions. Leakage in the anastomoses and stent loss prior 
to 20 days changed the inflammatory profile and gave rise to scar tissue formation and 
stricture. Future studies are needed in order to see whether these differences account 
for a regenerative healing process, with functional tissue reforming in the esophagus.
Keywords: long-gap esophageal atresia, pulmonary physiology, esophageal replace-
ment, guided tissue regeneration, macrophage phenotype, extracellular matrix
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List of Abbreviations
EA   Esophageal atresia
LGEA  Long-gap esophageal atresia
PVC  Polyvinylchloride
LES  Lower esophageal sphincter
ECM  Extracellular matrix
SIS  Small intestinal submucosa
VU  Vertebral units, a vertebral body with a disc.
RI   Reflux index
MBW  Multiple breath washout
LCI  Lung clearance index
FRC  Functional residual capacity
FEV1  Forced expiratory volume within 1 second
FVC  Functional vital capacity
TLC  Total lung capacity
SGA  Small for gestational age
LLMI  Lipid-laden macrophage index
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Introduction
Introduction
Esophageal atresia (EA) is a congenital malformation in which the separation of 
the foregut bud into the esophagus and the trachea is affected. There are five main 
subtypes of the malformation, depending on the presence of a fistula between the 
esophagus and the trachea, where it is situated and whether or not there is a dis-
continuity in the esophagus (1). In about 8% of the patients there is no fistula from 
the lower esophageal segment and the trachea. These patents often have a lack of 
esophageal tissue, which makes an esophageal anastomosis difficult (2,3,4). Today, 
these patients are treated with a delayed primary anastomosis or by some kind of 
replacement (5,6). These procedures involve long hospitalization and increased sur-
gical risks compared with when a primary anastomosis can be achieved (7). 
Experimental esophageal replacement in animals has been developed so that patch 
repair can be performed with the regeneration of functional esophageal tissue , but 
strictures and scars always occur after circumferential resections of the thoracic 
esophagus (8,9,10,11).
Recent advances in regenerative medicine have shown that the inflammatory pattern 
in a healing wound can be adjusted so that functional tissue, rather than scarring, is 
formed during the healing process(12,13). Further studies of circumferential resec-
tions of the thoracic esophagus are needed to develop a treatment for replacing the 
esophagus in EA patients with a lack of tissue, in order to enhance the function and 
reduce the surgical risks. 
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Back ground
Background
Esophageal atresia
History
Esophageal atresia (EA) was first described in 1670 by William Durston, but it was 
not until 1935 that the first child born with esophageal atresia survived (14,15). 
Since the 1940s, when the first successful primary anastomosis was performed, sur-
vival has increased to more than 90% (3,16). In recent years, the focus has shifted to 
the morbidity present among these patients and how to diminish it.
Etiology 
EA is the result of a defective separation between the esophagus and the trachea 
when the foregut develops into these structures. It is known that there is a slightly 
increased risk in the siblings of affected individuals, suggesting that there is a genetic 
factor. However, the majority of cases are sporadic. (17,18)  
 
Epidemiology
EA has a described incidence of between 3-4/10,000 newborns (3,19). It is slightly 
more common in males, among Caucasians and with increasing maternal age(20,21). 
Classification
The most commonly used classification of the different types of esophageal atresia is 
the classification proposed by Gross in 1953(1). 
 A 7%
Isolated EA
B 1% 
EA with
proximal fistula 
(TEF) 
C 86%
EA with 
distal TEF
D 2%
EA with 
proximal and 
distal TEF
E 4%
Only TEF
(H-type)
Figure 1. Classification according to Gross, with the proportion of each subtype. With 
permission Vladimir Gatzinsky
In order to describe the difficult cases without a distal fistula (Gross A+B), the term 
long-gap esophageal atresia (LGEA) is used (3,23,24). The definition of LGEA is 
controversial. At first, the definition was only used for patients born without a distal 
fistula (Gross A+B) and with a short distal pouch which prevented a primary anas-
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tomosis (2,22,23). Later on, many authors used the term for all patients in whom a 
primary anastomosis could not be performed in the neonatal period (4,24,25). 
Associated anomalies
Associated malformations are commonly seen in patients born with EA and affect 
as many as 50% of the patients. The incidence is higher in individuals without a 
distal fistula compared with the others. About 5% of patients have chromosomal 
abnormalities (26). 
 
Diagnosis
EA is suspected when a newborn has excessive salivation and regurgitates, or chokes 
and coughs when fed. The inability to pass a feeding tube into the stomach raises 
the suspicion still further. A plain X-ray of the chest and abdomen often produces 
the diagnosis[Figure 2]. 
Figure 2. Plain x-ray of a patient born with esophageal atresia.
If the diagnosis is still unclear, an esophagogram with contrast installation confirms 
the diagnosis. If the abdomen is gasless, there is no connection between the lower 
esophageal segment and the airways.  
Detection of the malformation antenatally is difficult, but it may be suspected if the 
ventricle is absent or small for age, combined with the presence of polyhydramniosis. 
If a blind-ended upper esophageal pouch can be visualized by ultrasound, this has 
been shown to have a positive predictive value of 100% (27).  
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Surgery
If the patient has gas in the abdomen, showing that there is a distal fistula, the first 
surgical procedure is a thoracotomy with the aim of achieving a primary anastomo-
sis. If the abdomen is gasless, a laparotomy is performed with measurements of the 
gap, with something radiopaque in both the esophageal segments [Figure 3]. 
Figure 3. Fluoroscopic picture of a long gap esophageal atresia patient with a Hegar-
dilator in the lower esophageal pouch(L) and contrast agent in the upper pouch(U).
U
L
Some authors advocate endoscopic cannulation of the distal segment, while others 
recommend a dynamometer in order to have fixed pressure when measuring (4,28). 
If the gap is less than 2 VUs, a primary anastomosis can be performed. Otherwise, 
a gastrostomy is constructed and a suction catheter is placed in the upper esopha-
geal pouch, to drain the saliva. The patients are nursed on the ward and regular 
measurements of the gap are made. As the lower esophageal segment tends to grow 
more rapidly than the child in the first months of life, the gap often diminishes, 
which allows for a delayed primary anastomosis (3,6). If the gap remains too large to 
bridge, elongation procedures on the upper pouch (29,30), gastroplasty (31,32,33) 
or esophageal replacement can be performed. Some of the methods are only suitable 
for bridging small gaps, whereas others can replace the entire esophagus from the 
neck to the abdomen, i.e. an esophageal replacement. When it comes to esophageal 
replacements, the small bowel, colon and stomach can be used (5,34,35,36). When 
the stomach is used, either a total gastric pull-up or a gastric tube can be constructed 
from the major side of the ventricle (35,37). All these methods have increased mor-
tality and morbidity compared with a patient in whom a primary anastomosis can 
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be performed (5). There is no consensus in the pediatric surgical community on 
which method should be used. Foker et al. have shown that it is possible to close the 
gap by traction of the esophageal pouches over a period of days (38). In a follow-up 
study, the patients had good function in the esophagus and good quality of life (39). 
The method has not worked this well at all institutions and the results appear to be 
in line with, or even worse than other methods for reconstructing LGEA (24,40). 
If there is a distal fistula and a thoracotomy is performed, there is sometimes still a 
lack of tissue, which makes a primary anastomosis difficult (3,4). The same length-
ening procedures as those described above can be used to achieve sufficient length 
for a primary anastomosis. Another strategy is to close the fistula between the distal 
esophageal pouch and the airways and then construct a gastrostomy. The patient can 
then be fed through the gastrostomy, while waiting for the final reconstruction. This 
approach is mainly advocated for very low birth weight patients, where more exces-
sive surgery is deemed too challenging (41,42). Any further growth of the esophageal 
pouches has never been documented in this situation, but the child will grow larger 
and this will hopefully facilitate the definitive surgery.  
Outcome
The overall survival rate nowadays is more than 90%, with most of the deaths attrib-
uted to non-avoidable causes. There are sporadic cases of death due to complications 
of the malformation and its treatment (7,43,44). Morbidity associated with the mal-
formation and its treatment are common. Short-term morbidity is mainly associated 
with the surgical procedure and includes anastomotic leakage, stricture, recurrent 
fistula, thrombosis and sepsis (7,43,44,45,46,47).
Long-term morbidity originates from both the airways and the upper gastrointes-
tinal tract. Dysphagia and gastroesophageal reflux are the most common problems 
from the gastrointestinal tract. Failure to thrive, or the need for sustained nutrition 
through a gastrostomy are more serious problems which can arise in more difficult 
cases. The risk of both short- and long-term morbidity from the gastrointestinal 
tract increases in patients in whom a primary anastomosis is difficult to achieve 
(7,44,45,48,49). When an esophageal replacement is performed, mortality rates of 
0-15% have been described (5,50). In the few comparative studies performed be-
tween different methods, the complication rates vary and there is no consensus on 
which method to use (5,51,52). Traction elongation of the esophageal pouches prior 
to anastomosis appeared to be very good when performed by Dr Foker (39), but 
other groups have had difficulty reproducing his astonishing results (40,45,49). In 
an animal model, where esophageal traction was applied to the rat esophagus, the 
esophagus was longer and heavier in the rats exposed to traction of the distal part 
of the esophagus. Histology showed a preserved structure but also the presence of 
torn muscle fibers and scarring (53). Further follow-up time is needed before it can 
be shown that the elongated esophagus stimulated by traction is of value to LGEA 
patients.
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Airway symptoms are also common after repaired EA (43,54). Animal studies have 
implied that the airways are included in the malformation, with pulmonary hypo-
plasia and tracheomalacia as inherent parts (55,56). In humans, these changes prob-
ably account for some of the airway symptoms. Dysphagia and gastroesophageal 
reflux are other causes (56,57,58). Tracheomalacia has been shown to be strongly 
associated with EA with a fistula (Gross B,C,D and E ) (59,60). To our knowledge, 
as EA Gross C is by far the most common type of EA, all pulmonary function stud-
ies have been performed in this patient group (54,57,61,62). 
The extent to which each of these factors contributes to the airway problems in each 
subgroup of EA patients is therefore still unclear.
Experimental models for esophageal replacement
As mortality and morbidity have been high after esophageal resections, whatever the 
cause, interest in developing better replacements has been shown since the mid-20th 
century. The first successful replacement of 5 cm of the intrathoracic esophagus in 
an experimental model was performed by Berman in 1952 (63). Using a PVC tube, 
he was able to bridge a 5 cm gap in the lower part of the esophagus. The animal 
survived and developed a tube made of scar tissue around the bridging graft. Ber-
man treated 60 patients undergoing esophageal resections due to cancer with this 
bridging graft and reported low rates of acute complications, even if the long-term 
mortality from the disease remained high (64).
In 1962, Boyd used different artificial prothesis to bridge a 5 cm gap in the esopha-
gus of pigs(65). He concluded that pigs were better animals for studying esophageal 
replacements, as their muscle composition in the esophageal wall is similar to that of 
humans, with skeletal muscle in the most proximal part of the esophagus, smooth 
muscle in the distal part and a mixture of both in between (66,67,68). Stricture re-
mained a significant problem in his model(65). Both dogs and rodents have skeletal 
muscle all the way down to the lower esophageal LES, which might affect the way 
the tissue heals after damage, thereby making them less suitable for developing treat-
ments designed for use in humans.
In 1965, Lister et al. used a bridging graft composed of a Marlesh® mesh and part of 
the rectus fascia to bridge a 3 cm long gap in the esophagus of growing puppies. If 
the stent was lost prior to 3 months, stricture occurred. However, if the graft stayed 
in place for that time, the animals developed well. At sacrifice, the bridging area 
was composed of scar tissue, but the length of the scar diminished with time. After 
nine months, only a narrow scar remained between the distal and proximal muscle 
edges (69).
Yamamoto et al. developed a canine model in the 1990s in which they used a sili-
cone tube with precipitated collagen around it as a bridging graft. With this graft, 
they were able to bridge 5 cm long defects on the neck with perfect histological end 
results, whereas a scar always developed when the replacement was performed in the 
thorax (11,70). When they seeded the graft with cells from the buccal mucosa, they 
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obtained faster coverage with mucosa but not better histology in the external muscle 
coat. Wrapping omentum around the bridging graft gave rise to more complications 
and much poorer healing in the area (71,72).
At the end of the 20th century, sheets of extracellular matrix (ECM) extracted from 
different tissues in animals/humans were studied as replacements in different organ 
systems (73,74,75). Used as a replacement in dogs, rats and pigs, almost total restitu-
tion of the esophageal wall was achieved after patch repair. However, stricture was 
inevitable after circumferential resections (8,9,10). One of the first commercially 
available ECMs was extracted from small intestinal submucosa (SIS). SIS is available 
as sheets, which were initially called Surgisis®. Due to some structural enhancements 
(more fat and DNA extracted from the ECM), the product name was changed to 
Biodesign® (76).
When ECM meshes have been studied in different replacement models, attention 
has been drawn to differences in the immune response to the replacement and par-
ticularly to differences in the macrophage phenotype (12,13). When the macro-
phages are classically activated, i.e. M1 macrophages, they promote further inflam-
mation and the healing process ends up with scarring. When the macrophages are 
activated by other microbiological signals, they develop a different phenotype and 
are called M2 macrophages (12,13,77). These different activation modes are not two 
discrete phenotypes but rather a continuum of different activation states. Never the 
less, the division into M1 and M2 phenotypes has been able to explain differences in 
both histological and clinical outcome in studies of both disease and wound healing 
(74,78,79,80,81). When ECM-derived meshes have been used, the presence of M2 
macrophages has been favorable when it comes to achieving “reconstructive remod-
eling”, i.e. the reformation of functional tissue, rather than just scarring (74,78,80).
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Aims
To describe the outcome for LGEA patients and to develop an experimental model 
of esophageal replacement aimed at improving the outcome after surgery in patients 
with LGEA
The specific aims in each paper were as follows. 
Paper I:  
To describe the clinical features, surgical treatment and outcome after one   
and seven years in patients treated for LGEA
Paper II: 
To develop an experimental model to study the replacement of a part of the intra-
thoracic esophagus in growing piglets and to describe the clinical and histological 
outcome
Paper III: 
To evaluate factors influencing the histological and clinical outcome 10 days after 
surgery and to develop the surgical technique to achieve optimal outcome
Paper IV: 
To evaluate factors which affect the histological and clinical outcome 20 days after 
surgery, with special emphasis on the inflammatory pattern
22
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Material and method
Material and method
Clinical study (Paper I)
All patients, eight boys and eight girls, born with LGEA between 1995 and 2010 in 
the western region of Sweden (2.5 million inhabitants), were consecutively included 
in this retrospective observational study. Ten of 16 (60%) had associated malforma-
tions and 3/16 (20%) were twins. 
LGEA was defined as an abdominal X-ray with a gasless abdomen, combined with 
a distance between the upper and lower esophageal segment that was ≥ 4 vertebral 
units (VU) at the first measurement.
The median follow-up period was 6.5 years (range 2-15). The patients had been fol-
lowed according to a structured follow-up program, where physiological tests had 
been performed at one and seven years of age. Weight and stature had been recorded 
regularly when the patients had been in contact with the hospital. 
Gastroesophageal reflux disease was defined as poor function in the lower esopha-
geal sphincter, causing symptoms such as retrosternal pain (heartburn), regurgita-
tion, vomiting, poor weight gain and/or recurrent airway infections. The monitoring 
of 24-hour pH was performed using the Synmed system. From the 24-hour pH 
monitoring, a reflux index (RI) was calculated, as the time with a pH lower than 4 
divided by the total time of the investigation in the distal part of the esophagus. An 
RI above 10% was considered pathological in the patients one year of age and an RI 
above 4% was considered pathological in the seven-year-old patients (82).
Weight and height development over time is compared with the normal population 
and also with other patients born small for gestational age. 
Lung function was assessed with spirometry and multiple breath washout (MBW) 
at one and seven years of age (83,84,85,86). From the spirometry, an obstructive or 
restrictive breathing pattern was assessed and, from the multiple breath washout, a 
lung clearance index (LCI) was calculated. 
At one year of age, the tidal breathing time to peak flow related to total expiration 
time, the maximum flow at FRC during tidal-volume rapid thoracic compression 
and the shape of the tidal breathing flow-volume curve were assessed. At seven years 
of age, the FEV1/FVC ratio, mean expiratory flow (ml/s) and reversibility (increase 
in FEV1 after an inhalation of salbutamol (%)) were used to assess the airway ob-
struction. If two of three of these had changes indicating an obstruction in the air-
ways, the patients were deemed to have an obstructive ventilatory disorder. 
A restrictive ventilatory disorder was suspected at one year of age if the FRC was > 
-2SD. At seven years of age, a restrictive ventilatory disorder was defined as a TLC 
of < -2SD or the combination of FEV1 and FVC < -2SD, together with a normal or 
high FEV1/FVC ratio. The presence of normal TLC ruled out a restrictive disorder. 
MBW is a method for assessing pulmonary ventilation inhomogeneity as a func-
tion of the peripheral airways. To summarize, an inert marker gas (sulfur hexafluo-
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ride) was inhaled during tidal breathing via a mouthpiece until an equilibrated gas 
concentration of 4% in inspiration and expiration was reached. In infants, a face 
mask was used and the patients were sedated with chloral hydrate (70 mg/kg body 
weight). After removing the inert gas, the gas was washed out from the lungs by the 
tidal breathing of room air. The cumulative expired volume necessary to reduce the 
end-tidal inert gas concentration from 4% to 0.1% was divided by the functional 
respiratory capacity (FRC). This ratio is expressed as the lung clearance index (LCI). 
The mean value of three recordings is reported and given in standard deviations re-
lated to results from healthy children(87). Gas concentrations were measured using 
a mass spectrometer.
Bronchoscopy and bronchoalveolar lavage were performed in patients with signifi-
cant symptoms from the lungs or esophagus, prior to surgical intervention. These 
investigations were performed under general anesthesia. 
 
The data and results for the growth of the patients were calculated in SD scores 
for the study group against the norm populations (general, twins, Mb Down and 
SGA populations). Comparisons with norm populations were performed using Wil-
coxon’s signed-rank test applied to the SD scores. Changes in SD scores over time 
were analyzed using Wilcoxon’s signed-rank test. All the tests were two-tailed and 
conducted at the 5% significance level. The data were analyzed using version 9 of the 
SAS System for Windows. 
Experimental studies (Papers II, III and IV)
In the experimental work, a model for the esophageal replacement of the thoracic 
esophagus through a right-sided thoracotomy had been developed. The resection 
was performed at the level of the tracheal branching into main bronchi, as this is 
the level at which esophageal tissue is missing in LGEA patients. The bridging graft, 
composed of a 4-ply Biodesign® mesh, sewn around a silicone tube, had been an-
chored using telescopic techniques at both the proximal and the distal end to avoid 
leakage [Figure  4]. 
Figure 4. Bridging graft sewn into the esophagus in an experimental animal. Gap length 
between the muscles edges are 3 cm.
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The piglets were put in the supine position and a small laparotomy was performed to 
construct a gastrostomy using an 18 to 26 ch Nelaton catheter, tunneled subcutane-
ously to the back of the pig [Figure  5]. 
Figure 5. Experimental animal in the animal housing a week after surgery. The gastros-
tomy catheter used for feeding is seen under the yellow wrapping.
Piperacillin 200 mg/kg + Tazobactam were given preoperatively and on the first 
postoperative day. A total of three doses were given. The piglets were fed through the 
gastrostomy until oral feeding was introduced. Rimadyl® (Carprofen) and Temgesic® 
(Buprenorphine) were given postoperatively to avoid postoperative pain. The ani-
mals had no bedding, to avoid the accumulation of bedding material in the esopha-
gus, giving rise to obstruction. Two animals shared a room, but they were divided 
by a fence as long as they had a gastrostomy, to avoid damage. They were euthanized 
according to schedule after surgery, or if they showed signs of complications, such 
as leakage and stricture. After sacrifice, an autopsy was performed in which the 
bridging area was evaluated macroscopically and fixated for immunohistochemical 
analysis, as well as for electron microscopy.
In Paper II, six piglets underwent surgery. The bridging graft was constructed by su-
turing a 4-ply Biodesign® mesh around a 1.5 mm thick, 8 cm long silicone tube, with 
an outer diameter of one cm. Both the proximal and distal anastomoses were sewn 
with the mucosa and the external muscle coat at the same position, 1.5 cm from 
the center of the graft, using eight interrupted sutures of 5-0 monocryl (Ethicon®) 
[Figure  6a]. The silicone tube was anchored with two sutures of 3-0 Ethilon® at the 
proximal end and two sutures of 3-0 Vicryl® at the distal anastomosis. 
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Figure 6. Schematic drawings of the fixation of the bridging graft in the experimental 
model.   The mucosa is yellow, the esophageal muscle coat red, the Biodesign mesh is beige 
and the silicone stent is gray in the drawing. A) Fixation performed in paper II. The 
mucosa and the external muscle coat was sewn with interrupted sutures in one layer B) 
Fixation performed in paper 3. The mucosa was sewn with interrupted sutures in method 
1, and with running sutures in method 2 and 3. Method 2 was used for the animals in 
paper 4.
A
B
The piglets were fed through the gastrostomy for four weeks. Dilation of the esopha-
gus was carried out when a pig showed signs of stricture: increased salivation, longer 
feeding time and vomiting. Esophageal videofluoroscopy was performed using a 
Philips fluoroscope, with the animal in a wooden cage [Figure  7a,b]. The piglets 
were sacrificed at 1, 3, 4, 6, 8 and 17 weeks respectively.
In Paper III, 10 piglets underwent surgery. The first four piglets had a 60 Shore-A 
silicone stent, 7.5 cm long, 10 mm wide, with a 1.5 mm thick wall. Shore-A defines 
27
Material and method
Figure 7. Set-up for fluoroscopic examinations of the esophagus in the experimental study II.
A
B
the hardness of the silicone stent. When applied, the mucosa was sewn 5 mm from 
the edges and the musculature about 2 cm from the edges, in order to have a large 
zone of contact between the esophageal musculature and the Biodesign® mesh. The 
anastomosis was sewn with four to five interrupted sutures of 4-0 Biosyn at both 
ends. The stent was fixated both distally and proximally with Neurolon 2-0 [Method 
1,Figure  6b]. The second four piglets had a bridging graft made of a 4-ply Biodesign 
mesh, sewn around a 60 Shore-A, 9 cm long, 10 mm wide silicone stent, with a 1 
mm thick wall. The anastomosis between the esophageal mucosa and the Biodesign 
mesh was sewn with running sutures with biosyn 4-0 0.5cm from the edges of the 
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bridging graft. The musculature was fixed 2 cm from the end of the Biodesign mesh 
with interrupted sutures of Biosyn 4-0. The stent was fixed with one suture of Neu-
rolon 2-0 both distally and proximally (Method 2,Figure  6B).
The last two piglets had a bridging graft made of a 4-ply Biodesign mesh, sewn 
around a 60 Shore-A, 9 cm long, 10 mm wide silicone stent, with a 1 mm thick wall. 
The esophagus was divided and a total of 3 cm of the musculature was resected after 
the mucosa had been retracted into the lumen. In this way, we made sure that more 
muscle than mucosa was resected. The mucosa was attached to the Biodesign mesh 
0,5 cm away from the center with running sutures of Biosyn 4-0. The musculature 
was fixed together with the silicone stent with Neurolon 2-0 in order to make sure 
that no musculature was in contact with the Biodesign mesh (Method 3,Figure  6B).
The animals were fed though gastrostomy until sacrifice. Sacrifice was planned 7-10 
days after surgery for practical purposes. If there was signs of mediastinitis, the 
animals were euthanized prior to the planned date. Histology was performed using 
immunohistochemistry to map out the distribution of smooth-muscle cells, inflam-
matory cells and the mucosa in the bridging area.
In Paper IV, six piglets underwent surgery according to Method 2 in Paper III (Meth-
od 2,Figure  6B) and they lived for 20 days after surgery. They were fed through 
gastrostomy for 10 days and ate probe formula orally for another 10 days prior to 
sacrifice. Nexium® was given orally to piglets 3-6 in order to avoid acid-related dam-
age to the healing area and to relieve acid-associated symptoms in the animals.
In animals 5 and 6, pledgets were used to secure the silicone stent to avoid stent loss 
prior to 20 days. Immunohistochemistry was performed to map the distribution 
of connective tissue, smooth-muscle cells, inflammatory cells and nerves. Selective 
antibodies were used to distinguish proinflammatory M1 macrophages from remod-
eling M2 macrophages.
All the studies were conducted according to good clinical standards and with ethi-
cal permission from the animal ethics committee of the western region of Sweden.
 
Cells/ extracellular component stained Histological marker
Pericyte, Smooth mucle cell, Skeletal muscle cell Desmin
Smooth muscle cells, myofibroblasts Smooth muscle actin
Smooth muscle cells Smooth muscle myocin
Basal membrane Laminin
T-Lymphocytes CD3
M1-macrophages, neutrophil granulocytes Calprotectin
M2-macrophage CD163
Small synaptic vesicles, nerve specific Synaptophycin
Table 2. Shows the antibodies used to visualize the different cell types and extracellular 
components.   
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Clinical study (Paper I)
Surgery
The mean age at definitive surgery was 147 days(Range 60-240).  Eleven patients, 
in whom the segments had grown to a distance of less than two VUs, had a delayed 
primary anastomosis. Three cases had a gastroplasty and two a colonic interposition. 
We have used gastroplasty when the patients only needed a shorter elongation in 
order to achieve an anastomosis and a colonic interposition when a longer defect had 
to be bridged. Five of 16 (30%) patients required further surgical procedures due to 
gastroesophageal reflux. 
Eleven of 16 (79%) patients required three or more dilations during the study period 
and anastomotic leakage was seen in 7/16 (45%) patients. In the patients undergoing 
delayed primary anastomosis, 6/11 (55%) had an anastomotic leakage, where two 
required a re-operation with resutering and open drain placement.
At the end of the study period, 14/16 patients were on continuous PPI treatment, 
while the other two were among the five patients who had reflux surgery performed 
after the definitive repair. 
pH monitoring at one and seven years of age did not correspond to the future need 
for surgical intervention. At the end of the study period, 7/16 still had a gastrostomy 
to aid nutrition. All the patients were able to drink orally, but two were unable to 
eat solid foods. 
Growth 
At birth, the patients were small in weight, -2.3 SD (Range -4 - 0,2) and stature, 
-1.1 SD (Range -4 - 1.2) for gestational age and they continued to be small at one 
(Weight -2 SD(Range -3.2 - 0), Stature -1.7 SD(Range -4.5 - 0.8)) and seven (Weight 
-1.1 SD(Range -3 - 0), Stature -1.7 SD(Range -3.2 - 0) years of age. There was a sta-
tistically significant catch-up in weight between birth and seven years of age, but no 
catch-up in stature. [Figure  8 A,B]
Lung function
Pulmonary physiology was performed in seven patients at one year of age and in 
eight patients at seven years of age. One patient at the beginning of the series de-
clined testing, while one patient at the end of the series was not tested in the study 
period due to severe comorbidity. One patient was tested at both one and seven years 
of age. The LCI was normal in 11 measurements and increased in four. Three of the 
four patients with an elevated LCI required further surgery to avoid gastroesopha-
geal reflux and/or aspiration. At the age of one year, four of seven patients (57%) had 
signs of airway obstruction in spirometry, but only one of these needed treatment. 
At the age of seven years, three of eight patients (38%) had airway obstruction at 
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spirometry. At one year of age, no patient displayed a restricted ventilation pattern, 
but this was noted in two patients at seven years of age.
Bronchoscopy had been performed as part of the gastroesophageal reflux evaluation 
in 6/16 patients. In three of six patients (nos 7, 10, 11), the lipid-laden macrophage 
index (LLMI) was ≤ 20. Intensified treatment with inhalations relieved their symp-
toms and no further anti-reflux surgery was performed to protect their airways. In 
two of six patients (nos. 3, 14), the LLMI was 48 and 50 respectively. Aspiration was 
suspected due to the clinical picture and other investigations. Further surgery was 
required to avoid progressive pulmonary damage. In one patient (no. 6), food was 
seen in the airways and surgery was performed to prevent further aspiration. 
Figure 8. Height and weight development in LGEA patients given in SDS. The height 
and weight have been normalized for gender, Mb Down and twins. The Ref SGA(L) 
line seen in A is computed from data relating to the growth of children born short for 
gestational age. A) Height SDS B) Weight SDS.
A B
Experimental studies (Papers II, III and IV)
In Paper II, all the pigs survived surgery and gained weight proportionally to their 
age during the study period. Four of six animals lived for longer than four weeks 
and, in this group, stent loss was 2/4. There were no cases of leakage from the esoph-
ageal anastomosis that required intervention, even though all the piglets showed 
signs of mediastinitis during the first week after surgery, with fever, gastrointestinal 
paralysis and vomiting.
After the stent was lost, stricture developed in all animals and it was treated with 
dilations in three animals [Figure  9]. In piglets nos 1, 3 and 6, histology showed 
fibrous tissue in the bridging area but also islets of desmin-positive cells, with a large 
nucleus and sparse amounts of organelles at electron microscopy [Figure 10,11,12]. 
Their appearance in electron microscopy was similar to pericytes seen in sprouting 
vessels (88), but here the cells appeared in clusters in the esophageal wall, not in 
the vessel wall. In piglet no 6. elongated desmin-positive cells, resembling mature 
smooth-muscle cells, could be seen in the bridging area [Figure 13]. In piglets nos 2, 
4 and 5, only connective tissue and inflammatory cells were seen.
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Figure 9. Fluoroscopic images of a dilation in an experimental animal in Paper II. A 
Bard® balloon catheter has been used, and a pressure of 2,5 atmospheres. A) Before dila-
tion. B) In the middle of the dilation c) After Dilation.
In Paper III, 10 piglets underwent surgery. Three of four piglets undergoing sur-
gery according to Method 1 had leakage, which gave rise to sacrifice due to signs 
of mediastinitis or fistulation between the esophagus and the thoracotomy wound. 
Adjustment of the suturing technique and silicone tube was performed for the next 
four piglets (Method 2). They had no clinical signs of leakage and, at sacrifice, a 
macroscopic tissue tube bridged the gap between the proximal and distal esophageal 
edges [Figure 14]. Piglets nos 9 and 10 underwent surgery according to Method 3, 
both had significant leakage and no 9 was sacrificed prior to plan due to symptoms 
of mediastinitis. Histology showed that the bridging area consisted of a layer of in-
flammatory cells towards the esophageal lumen. Towards the adventitia, there was 
a layer consisting of inflammatory cells, sprouting vessels and smooth-muscle cells. 
Longitudinal sections of the bridging area showed that the mucosa was thin over the 
native muscle layer and it was then replaced by a layer of inflammatory cells towards 
the lumen [Figure 15]. Double staining with laminin and desmin revealed a thin 
basal membrane over some of the pericytes in the sprouting vessels in the bridging 
area and there were pericytes which looked as though they were about to detach 
from the vessel wall [Figure 16]. 
In the animals with significant leakage, a more aggressive inflammatory pattern was 
seen, with calprotectin-positive cells in the native muscle layers close to the bridging 
area and more, larger islets of CD3-positive islets in the bridging area. 
In Paper IV, six piglets underwent surgery and lived for 20 days until sacrifice. They 
underwent surgery according to Method 2 in Paper 2. In the animals given Nexium 
(3-6), no signs of nausea or reflux were present. Two of six piglets had stent loss prior 
to 20 days, which gave rise to clinical signs of esophageal obstruction. At autopsy, 
the bridging area was easy to identify and retrieve in the animals with a retained 
silicone stent and the Biodesign mesh could be seen inside the bridging area. If the 
stent was lost, the adhesions between the bridging area and surrounding tissue were 
firmer and required sharper dissection for retrieval and the Biodesign mesh was lost 
together with the stent.
Histology from the bridging area of the piglets in which the stent was preserved had 
the luminal side covered with mature mucosa up to the edges of the native muscu-
laris externa [Figure 17]. 
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Figure 10. Electron microscopic images of the bridging area. A) In the center of the im-
age a cell, almost devoid of organelles, is visible with the characteristics of an activated 
pericyte (P). In the upper left a probable fibroblast, rich in granulated ER, is seen (F). In 
the lower right a vacuole-rich macrophage (M) is found.
B) A sprouting vessel and the tip of endothelial cells (E) can be seen underneath a thick 
porous basal membrane (BM). On the outer rim of the BM a pericyte (P) is seen which 
seemingly is projecting towards the surrounding tissue.
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Figure 11. Paraffin section from the regenerating esophagus 4 weeks after operation. The 
section is processed to demonstrate desmin. Large cells often arranged in groups of 2 or 
more are seen. Bar = 50 µm.
Figure 12. Paraffin section from the regenerating esophagus 16 weeks after operation. 
The section is processed to demonstrate desmin. A cluster of desmin-positive cells are situ-
ated in the lamina propria below the regenerated epithelium. Bar = 500 µm.
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Figure 13. Paraffin sections from the edge of the bridging area 16 weeks after surgery. 
The section is processed to demonstrate desmin. Close to the cut, native esophageal muscle 
spindle shaped desmin positive cells are seen in the bridging area.
Figure 14. Macroscopic pictures of the bridging area at autopsy 9 days after surgery. A) 
Esophagus together with trachea is seen. The central white tissue is the bridging area, 
where the sutures can be seen under the newly formed connective tissue. B) The specimen 
divided in the center. Around the silicone stent, the Biodesign mesh can be seen under the 
newly formed tissue tube.
Figure 15. Longitudinal section from the proximal part of the esophagus 9 days after 
surgery.  Desmin positive cells are stained brown.
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Figure 16. Section from specimen 9 days after surgery. Laminin, a basal membrane pro-
tein in the vessel walls, is stained brown. Desmin, which is present in the pericytes of the 
vessel wall is stained red. The arrow shows a pericyte, which seems to leave the vessel wall.
Figure 17. Longitudinal section from the proximal part of the esophagus 20 days after 
surgery.  Desmin positive cells are stained brown. To the left the native muscle coat is 
seen. To the right is the bridging area, which contains smooth muscle cells organized in 
perpendicular layers. The specimen is approximately 1,2 cm long.
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Central to the muscle edges, the mucosa became thin and was replaced by calprotec-
tin-positive inflammatory cells. CD163 staining of the central portion of the bridg-
ing area revealed a rim of positive cells close to the lumen [Figure 18b]. Towards 
the adventitia, there was a layer of CD3-positive lymphocytes, which lay organized 
in strands and, further into the wall towards the adventitia, there was a layer of 
connective tissue where an abundance of new vessels and smooth-muscle, myosin-
positive cells could be seen. In the center, smooth-muscle cells were organized in 
two perpendicular layers. The smooth-muscle cells were not evenly distributed but 
appeared in clusters throughout the entire bridging area. They were thicker and 
more organized in the center of the bridging area compared with the proximal and 
distal parts. Islets of calprotectin-positive cells and neutrophils persisted in the wall 
[Figure 19]. The center of the bridging area was stained for synaptophycin. In piglet 
5, the vagal trunk could be seen on the outside of the regrown tissue. Close to the 
nerve, a small nerve was seen projecting into the outer part of the healing tissue, 
embedded in the regenerated layer of connective tissue and muscle cells. In this 
specimen, more smooth-muscle cells could be seen on the side of the wall where the 
vagal nerve was situated. No nerve penetrating the regenerated area could be seen in 
the remaining piglets.
In the piglet in which the stent was lost, staining for calprotectin revealed an abun-
dance of positive cells throughout the entire wall of the bridging area. No CD163-
positive macrophages were seen. As the bridging area appeared to contract, it was 
difficult to distinguish layers of CD3-positive lymphocytes and desmin-positive 
cells. The extent of mucosal regrowth was difficult to determine due to the poor or-
ganization of the specimen. However, there were cells positive for both desmin and 
smooth-muscle myosin in the wall of the bridging area. 
CD163-positive macrophages in the bridging area were seen in all the piglets with 
the bridging graft in situ but could not be seen in the piglets in which the graft was 
lost. The difference did not become significant in terms of whether the stent/Biode-
sign was present or lost 20 days after surgery (P=0.07).  
In comparison, CD163 staining of the nine-day specimen revealed that there were 
sparse CD163-positive cells next to the lumen in the piglets where no leakage oc-
curred [Figure 18A,B].
The number of smooth-muscle cells in the center of the bridging area was more pro-
nounced 20 days after surgery compared with after nine days (Fig 15 and 17). The 
CD 3-positive layer separating the regenerating muscle from the esophageal lumen 
had developed between nine and 20 days after surgery.   
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Figure 18. Sections stained for CD163 from the center of the bridging area A) 9 days af-
ter surgery B) 20 days after surgery.  There is an accumulation of positive cells, close to the 
lumen at 20 days compared to  9 days after surgery. Some of the positive cells are encircled.
A
B
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Figure 19. Transverse sections from the middle part of the regenerated area. A and C 
from an animal in which the stent was retained for 20 days; B and D from an animal 
in which the stent was lost. In A and C, the position of the main cellular components 
are marked in the picture.( bm = biomaterial, cal = calprotectin, SMA = smooth muscle 
actin, SMM = smooth muscle myosin )
A and B processed to demonstrate SMA. A) The wall of the regenerated area is orga-
nized in distinct layers. The distribution of the of the main cellular components are 
marked in the picture (bm = biomaterial, cal = calprotectin, SMA = smooth mus-
cle actin, SMM = smooth muscle myosin).  B) The wall show no obvious organiza-
tion and the lumen in contracted. C and D processed to demonstrate calprotectin. 
Bars = 500 µm. Nuclei counter stained with hematoxylin
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Assoc anomalies Definite surgery
type
Definite 
surgery
(age, 
days)
Further surgical inventions
(age in years)
G = Gastro- intestinal
P = Pulmonary
GP=gastro and pulmonary 
symptoms
LLMI (age when 
BAL performed 
in years)
neutro i BAL
Summarized result of 
“spirometry”
N=normal
O=Obstrictive
R=Restrictive
FEV1/PEF
(A=no fistula, 
B=prox 
fistula)
LCI  (SD) Reflux index (%)    
Pathological:
at 1 year of age  >10%
at 7 years of age >4%
Age 1 Age 7 Age 1 Age 7 Age 1 Age 7
1 Mb Down, AV comm. Delayed end to end 60 Reoperation due to leakage No follow-up No follow-up - - 89 5
2 Mb Down Delayed end to end 156 - Technically 
incorrect
9,8   (A) - -1,2 3 2
3 Single kidney Delayed end to end 171 Collies gastroplasty (1)G  
Nissen fundoplication (2 2/12)GP, 
Pyloroplasty (7 7/12) G
48 (3 1/12)
20 neutro
43 (6 5/12)
12 neutro
21 (7 4/12)
6 neutro
- O 7,0   (A) - 13,4 14 30
4 VSD Delayed end to end 115 - N 10,1 (B) - -0,3 38 10
5 Delayed end to end 133 Nissen fundoplication (1 5/12) 
GP
- R 6,7   (A) - 2,2 16 1
6 Delayed end to end 229 Reoperation with resection and 
reanastomosis (11/12)G, 
Nissen fundoplication (1 1/12)G
Take down of a previous fundopli-
cation +myotomy+ pyloroplasty 
(9 5/12)GP
Food in airways 
(9 4/12)
- R 6,6   (A) - 3,9 0 0
7 Collies gastro-plasty 144 Reoperation due to leakage LLMI  No answer 
(1 yrs) 
70 neutro
(3 11/12)
18 neutro
- O 7,8    (A) - 1,9 28 0
8 Urethral valve Colonic inter-position 240 - O 7,2    (A) - 0,5 0 0
9 Anal atresia Delayed end to end 200 O N 10,6   (B) -0,9 1,2 18 11
10 Delayed end to end 150 Nissen fundoplication (2 5/12)G 20 (2 yrs)
1 neutro
O - A -0,3 - 2 -
11 Delayed end to end 81 LLMI < 10
(2 4/12 and 5 
2/12) 2009 0neut
O - A 0,4 - 3 -
12 Shärli/Rao Gastro-
plasty
133 N - B 1 - 57 -
13 No inferior caval vein, VSD Delayed end to end 150 N - A 0,7 - 5 -
14 Apert syndrome Delayed end to end 150 Nissen fundoplication (1 9/12)GP LLMI 50, 41 
neutro
(1 3/12)
O - A 3 - 16 -
15 Mb  Down Shärli/Rao Gastro-
plasty
165 N - B 0,2 - 21 -
16 Single kidney, VUR, hypo-
thyreosis, hyperinsulinism, 
malformed ear canals
Colonic inter-position 67 Not evaluated - A - - - -
Table 1. Clinical features. ( AV comm. = Atrio-ventricular septal defect, VSD = Venticle septum defect,         VUR = Vesico-urethral reflux, LLMI = Lipid-laden macrophage index, FEV1 = Forced expiratory 
volume in one second, PEF = Peak expiratory flow )
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General discussion
Even though survival among patients born with LGEA is high (3,7), these patients 
still have a great deal of morbidity from both the airways and the upper gastrointesti-
nal tract (43,44,45,62). Several authors have shown that problems from the airways, 
in the more common type of EA (Gross type C), originate to a large extent from 
the malformation rather than from gastroesophageal reflux with aspiration (56,61). 
Patients born with EA Gross type A, on the other hand, have been shown to have 
less involvement of the airways in the malformation (59,60). In our study, we found 
similar changes on spirometry examinations in patients with EA Gross type A, but 
the clinical manifestations appear to be attributable to gastroesophageal reflux with 
aspiration. MBW was within the normal range in 11 of 15 measurements (1 patient 
had 2 measurements) and three of four with an elevated LCI required surgery to pre-
vent aspiration and progressive pulmonary damage. This implies that MBW might 
be a valuable tool for monitoring pulmonary function in these children.
According to the most recent clinical guidelines, gastroesophageal reflux disease 
(GERD) is defined as “reflux of gastric content in the esophagus which causes trou-
blesome symptoms and/or complications” (82). In our study, all the LGEA patients 
have GERD, even if they are often asymptomatic due to adequate treatment. Other 
studies often report “Symptoms of GERD”, followed by a lower incidence of GERD 
postoperatively (43,44).
Children born with EA are born premature and small for their gestational age. In 
patients born with EA Gross C, pulmonary morbidity affects the same patients 
who have growth retardation (89). Growth retardation is therefore probably a sign 
of morbidity rather than an innate part of the malformation. In LGEA patients, 
growth has been shown to be “very acceptable” (6) or normal (90). In our series, we 
noted that the patients were both light and short at birth and stayed that way until 
seven years of age. As most of our patients were within ± 2SD, we were able to claim 
that they were within the normal range, but, as a group, they did not catch up in 
height at all, only in weight. As LGEA patients have longer periods of hospitaliza-
tion and more morbidity than the EA Gross type C, it is reasonable to suppose that 
their growth retardation is due to their morbidity. Future studies will show whether 
growth can be enhanced if morbidity can be reduced.
The terminology for children born with EA, where a primary anastomosis is difficult 
to achieve due to lack of tissue, is controversial. LGEA was initially only used for 
patients without a distal fistula (2,22,23). Other suggested abbreviations have been 
LGF (long-gap fistula), for patients with a distal fistula, and LGNF (long-gap non-
fistula), for patients without one (91). In recent years, LGEA has been used for all 
patients in whom a primary anastomosis has been difficult to achieve (4,24,25). As 
the postoperative morbidity might differ, not only secondary to excessive surgery but 
also due to underlying differences in the malformed organs, it seems reasonable al-
ways to define the anatomic subtype according to Gross when reporting the different 
outcome measurements. Bagolan et al. showed that, among their LGEA patients, 
defined as all patients with a distance between the esophageal pouches longer than 
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three vertebral bodies, patients with Gross type A+B EA(55%) had a poorer outcome 
than the C+D patients, with more dilations and more problems with prolonged oral 
aversion (4).   
In order to find a way to avoid some of the morbidity from which these patients 
suffer, we have developed a porcine model for studying guided tissue regeneration 
of 3 cm of the intrathoracic esophagus. Earlier work has shown that pigs are the 
most suitable animal for studying esophageal regeneration, as they have a muscle 
composition in their esophageal wall similar to that of humans (66,67,68). Children 
born with esophageal atresia always have smooth muscle in their distal esophageal 
segment (92,93). To our knowledge, the muscle composition at the bottom of the 
upper pouch has not previously been described. Replacement studies designed to 
help patients born with EA should therefore not be performed in dogs or rodents, as 
the results cannot be transferred due to the histological differences. 
Since the beginning of the 20th century, it has been known that amphibians have 
an extraordinary regenerative capability in most regions of their body (94,95). Even 
though factors which account for some of this remarkable capability to heal have 
been elucidated (95,96), no one, to our knowledge, has been able to trigger a heal-
ing response of this kind in mammals. In the field of regenerative medicine, meth-
ods to achieve some sort of functional replacement of tissue after removal or injury 
have been studied. Esophageal replacements with ECM scaffolds have shown very 
good results when used to bridge partial resections of the esophageal wall, whereas 
stricture has been unavoidable when circumferential resection has been performed 
(8,9,10,97). The reason for this difference in healing response is not known. Our 
results suggest that the healing process has the ability to regenerate functional tis-
sue, even after circumferential resections, but the process is sensitive and can eas-
ily be pushed towards scar healing. The M1/M2-macrophage paradigm, where the 
M2 phenotype enables regenerative healing, appears to work well when it comes 
to evaluating the healing process in the model. Factors which can be attributed to 
regenerative healing in the model could be mesh-muscle contact, ionic leakage over 
the created defect, nerve-macrophage interactions and much more. We are unable 
to tell whether any of these factors are important in our studies, but we plan to in-
vestigate this further. 
 
Several authors have added cells to the implanted scaffolds in order to enhance the 
histological outcome (72,74,98). In a rodent study, where ECM was prepared from 
rat esophagi and seeded with mesenchymal stem cells prior to transplantation, mus-
cular fibers were seen in the wall and the mucosa had healed over the graft after 14 
days, when part of the cervical esophagus was replaced. The cells were enhanced 
with green fluorescent dye in order to be able to follow the fate of the seeded cells. 
When the implant was explanted after 14 days, no green fluorescence was detected 
(98).  
When working on the replacement of the inferior caval vein in a murine model, it 
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has been shown that the mesenchymal stem cells improve the histological outcome 
by altering the inflammatory response in the graft rather than by being the building 
blocks of the reforming vessel (99). In our studies, the smooth-muscle cells in the 
bridging area might be recruited from the edges of the cut native muscle edges, but 
the morphology of the immature-looking cells in Paper II implies that it is the peri-
cytes of the ingrowing vessels that are the cellular origin of the regenerated muscle. 
Double staining for basal membrane and pericytes in Paper III also supports the 
hypothesis that pericytes leave the vessel wall of the ingrowing vessels to become 
smooth-muscle cells in the esophageal wall. In vitro, it has been shown that a sub-
set of human pericytes can be developed into several different tissues in the right 
organotrophic media (100). This implies that the scar healing, which is the most 
common end result after damage in humans, is not due to the lack of cells that can 
develop into functional tissue. If so, something else must be missing which prevents 
regenerative healing after damage. 
In amphibians, where regenerative healing is common after damage, a certain 
amount of nerve to the damaged area is needed (95,96). Goodwin et al. recently 
showed that macrophages are another necessary component for limb regeneration 
in amphibians (101). 
In our model, both leakage in the anastomosis early after replacement and stent/
mesh loss affect the inflammatory response in the bridging area during the heal-
ing process. By changing the surgical method, we have been able to achieve patent 
anastomoses. Under favorable conditions, smooth-muscle cells accumulate in the 
neoesophageal wall and the mucosa grows from the edges towards the center up to 
20 days after surgery. The bridging area is organized in separate layers with macro-
phages and neutrophils towards the lumen, with a layer mainly composed of strands 
of lymphocytes and vessels in the center. Further out towards the adventitia, a layer 
of connective tissue, including smooth-muscle cells, is seen. This organization im-
plies that the tissue develops into more functional tissue than just a scar. The fact 
that the smooth-muscle cells organize into two perpendicular layers also implies that 
there is some reformation of the esophageal muscle wall. 
Staining for an ingrowing nerve only revealed a possible sprouting nerve in one 
specimen after 20 days. This implies that either the healing process so far is nerve 
independent, or that the nerves are so sparse that they are easily missed when prepar-
ing the histological samples.  
An ingrowing nerve is seen in one sample, M2 macrophages are seen in the samples 
with the best histological outcome and an increased amount of muscle is seen with 
time in our model. This suggests that we are studying a healing process similar to 
that seen in amphibians, i.e. the regeneration of functional esophageal tissue.
When the animals were given Nexium orally after surgery, all symptoms of nausea 
in the animals disappeared. Nexium might also be beneficial to the histological de-
velopment of the bridging area, as it diminished the acid exposure of the area during 
the healing process. A longer follow-up time is needed to see whether this process 
ends up with the regeneration of functional esophageal tissue with time. 
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Discussion
Strengths and limitations
The main limitations of the clinical study (Paper I) are that it is retrospective and 
that there are few patients all with a very complex medical condition. The strengths 
are that all patients with a gasless abdomen and a long gap between the esopha-
geal pouches have been included and that they have been subjected to a structured 
follow-up protocol at one and seven years of age.
The main limitation of all the experimental studies (Papers II-IV) is the small sam-
ple size, which makes it impossible to identify factors beneficial to the outcome with 
statistical significance. 
The strengths are that the animals are meticulously cared for and that we have been 
able to develop the methods to achieve better histological and clinical outcomes, 
with a fairly small number of animals. 
As the follow-up time after surgery has been longer, the fast growth of Swedish 
pigs might be a problem, as the diameter of the silicone tube quickly appears to be 
outgrown. In the ongoing work in the porcine model, we hope to obtain a better 
estimate of how long a stent is needed to enable the optimal histological end result. 
If a longer stenting time is needed, the discrepancy in size between the stent and the 
native esophagus becomes too large. We then plan to examine the muscle histology 
in Göttingen minipigs, to see whether they are suitable for replacements studies with 
a longer follow-up time.
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Conclusions
Conclusion and further studies
Patients born with LGEA suffer from morbidity due to gastroesophageal reflux. 
Clinically available methods for esophageal replacement carry a lifelong increase in 
the risk of demise and poor function of the esophagus. MBW might be a valuable 
tool in the follow-up of these patients, for the early detection of aspiration into the 
lungs, which warrants swift action to avoid progressive pulmonary damage.
Experimental esophageal replacement with bridging grafts ends up with stricture 
and scar formation when used to replace part of the thoracic esophagus. In our mod-
el, we can see the presence of remodeling, M2 macrophages and an accumulation of 
functional tissue in the replaced area 20 days after surgery. Further studies focusing 
on the inflammatory pattern in the regenerating tissue during different time frames 
after surgery might help us to improve the outcome and develop a method which 
can be used in LGEA patients.
Further studies
Further studies of the replacement of the porcine esophagus are planned in order to 
follow the histological development of the bridging area under favorable conditions 
and to further develop the fixation of the silicone tube so that it stays in place for as 
long as it takes to secure an optimal end result.
Functional tests of the explanted tissue in the bridging area are planned, in order to 
evaluate muscular activity.
The connection between macrophage phenotype, nerve sprouting, ECM exposure 
and regeneration is planned to be investigated in an amphibian model, in order to 
find ways to improve regeneration
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Sammanfattning på svenska
Sammanfattning på svenska
Esophagusatresi (EA) är en missbildning av matstrupe och luftrör, som drabbar 
cirka 1 på 3000 födda barn. 10-15% av barnen har en missbildningsvariant där det 
är svårt att operera ihop de båda matstrupsanlagen. I de fall, cirka 8 %, där förbin-
delse mellan det nedre matstrupsanlaget och luftröret saknas, är det nästan alltid 
stor brist på matstrupsvävnad vid födseln. Idag opereras dessa barn efter tre månad-
ers väntan, då matstrupen ofta vuxit till. Om det fortfarande fattas vävnad får delar 
av matstrupen ersättas med en bit tarm, en del av magsäcken eller hela magsäcken. 
Dessa behandlingsmetoder medför en ökad kirurgisk risk och medför dessutom livs-
lång funktionsnedsättning i matstrupen.
Försök att ersätta delar av matstrupen i djurmodeller har pågått sedan 1950-talet. 
Genom att använda plaströr för att överbrygga defekter i matstrupen kunde man få 
ett rör bestående av ärrvävnad att bildas, som fungerade som passage mellan mun-
nen och magsäcken. Då detta rör inte har någon muskelfunktion kom metoden 
aldrig att användas hos barn. De senaste årtiondena har istället försök gjorts med rör 
gjorda av bindväv från människa eller djur. Dessa ombildas helt till matstrupsvävnad 
om man ersätter en ”lucka” av vävnad, men om man ersätter en circumferent del så 
bildas ärr och den nybildade strupen växer ihop.
Ny forskning rörande hur kroppen läker när renframställd bindväv används i sår har 
visat att läkningen är beroende av det inflammatoriska svaret från kroppen. Framför 
allt har man sett att en viss typ av vit blodkropp, makrofager, kan ha olika uttryck 
på sin cellyta, och därigenom styrs hela inflammationen i olika riktning. Den klas-
siskt aktiverade makrofagen, som aktiveras av till exempel bakterier, underhåller 
inflammation och slutresultatet av processen blir ärrbildning. Om makrofagen istäl-
let blir aktiveras på ett annat sätt, kan det istället dämpa inflammation, och i flera 
modeller av skador/sjukdom kan kroppen då nybilda funktionell vävnad. Vi har i 
våra studier kartlagt resultaten för de barn som opererats för EA utan förbindelse 
mellan nedre matstrupsanlaget och luftrören under 15 år i västra delen av Sverige. 
Barnen opererades vid ca 5 månaders ålder. Ca 70 % kunde opereras med en skarv 
mellan det övre och det nedre matstrupsanlaget, 5 stycken behövde en förlängning 
av matstrupen med hjälp av en del av magsäcken eller en del av tjocktarmen. Alla 
barn överlevde, men alla lider av gastroesophageal refluxsjukdom, som gör att de 
måste äta magsyrahämmande mediciner dagligen eller opereras mot reflux. Barnen 
är små vid födseln och fortsätter att vara små under uppväxten.
Lungfunktionsundersökningar utförda vid 1 och 7 års ålder har gjorts och visade en 
påverkan på luftvägarna som sannolikt är en del av missbildningen. En ny typ av un-
dersökning, ”Multiple breath wash-out” var normal hos flertalet av barnen, men hos 
de med förhöjt värde behövde 3 av 4(75%) opereras för att förhindra att mat kommer 
ner i lungorna. Denna undersökning förfaller vara av värde för att tidigt upptäcka 
de patienter som behöver en mer aggressiv behandling för att undvika lungskador.   
I en djurmodell har vi studerat om en del av matstrupen hos växande griskultingar 
kan ersättas med ett biomaterial utvunnet av gristunntarm. När vi ersätter 3 cm av 
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matstrupen har vi kunnat se att det ersatta området kan utvecklas till ett vävnadsrör 
som binder ihop matstrupsändarna inom 10 dagar efter operationen. Vävnadsröret 
strukturerar sig i tre lager. Innerst ses två lager med olika typer av inflammatoriska 
celler. Ytterst ses ett lager med bindväv och ökande mängder muskelceller 20 dagar 
efter operationen. I dessa preparat finns rikligt med inflammationsdämpande mak-
rofager. Om det läcker mellan matstrupens insida och utsida, eller om silikonröret 
som sätts in i matstrupen vid operationen släpper för tidigt, ändras den inflam-
matoriska bilden i vävnadsröret. De inflammationsdämpande makrofagerna förs-
vinner och området ärromvandlas och skrumpnar. Ytterligare studier med längre 
uppföljningstid behövs för att utröna om den mer gynnsamma histologiska bilden 
kan fortsätta i området och vävnaden utvecklas till ny fungerande matstrupsvävnad. 
Om hypotesen stämmer skulle det kunna bli en metod som förbättrar funktionen i 
matstrupen hos barn födda med EA. 
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